نتائج البحث - Roza Motavalli

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Berberine: A novel therapeutic strategy for cancer

    Berberine: A novel therapeutic strategy for cancer حسب Parisa Samadi, Parisa Sarvarian, Elham Gholipour, Karim Shams Asenjan, Leili Aghebati‐Maleki, Roza Motavalli, Mohammad Hojjat‐Farsangi, Mehdi Yousefi

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine

    A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine حسب Soudeh Moghadasi, Marischa Elveny, Heshu Sulaiman Rahman, Wanich Suksatan, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, Siavash Shariatzadeh, Roza Motavalli, Farahnaz Behzad, Faroogh Marofi, Ali Hassanzadeh, Yashwant Pathak, Mostafa Jarahian

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    CAR T cells in solid tumors: challenges and opportunities

    CAR T cells in solid tumors: challenges and opportunities حسب Faroogh Marofi, Roza Motavalli, В. А. Сафонов, Lakshmi Thangavelu, Alexei Valerievich Yumashev, Markov Alexander, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Mostafa Jarahian, Sepideh Izadi, Ali Hassanzadeh, Naghmeh Shirafkan, Safa Tahmasebi, Farhad Motavalli Khiavi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    CAR‐NK cell in cancer immunotherapy; A promising frontier

    CAR‐NK cell in cancer immunotherapy; A promising frontier حسب Faroogh Marofi, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, Hendrik Setia Budi, Abduladheem Turki Jalil, Alexei Valerievich Yumashev, Ali Hassanzadeh, Mahboubeh Yazdanifar, Roza Motavalli, Max Stanley Chartrand, Majid Ahmadi, Angel Cid‐Arreguid, Mostafa Jarahian

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions

    A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions حسب Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Klunko Nataliya Sergeevna, Wanich Suksatan, Walid Kamal Abdelbasset, M. V. Mikhailova, Navid Shomali, Mahboubeh Yazdanifar, Ali Hassanzadeh, Majid Ahmadi, Roza Motavalli, Yashwant Pathak, Sepideh Izadi, Mostafa Jarahian

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies

    A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies حسب Ehsan Razeghian, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, Zhanna R. Gardanova, Walid Kamal Abdelbasset, A. Surendar, Dmitry Olegovich Bokov, Wanich Suksatan, Pooria Nakhaei, Siavash Shariatzadeh, Faroogh Marofi, Mahboubeh Yazdanifar, Somayeh Shamlou, Roza Motavalli, Farhad Motavalli Khiavi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients

    A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients حسب Mohammad Sadegh Soltani‐Zangbar, Forough Parhizkar, Elham Ghaedi, Ali Tarbiat, Roza Motavalli, Amin Alizadegan, Leili Aghebati‐Maleki, Davoud Rostamzadeh, Yousef Yousefzadeh, Golamreza Jadideslam, Sima Shahmohammadi Farid, Leila Roshangar, Ata Mahmoodpoor, Javad Ahmadian Heris, Abolfazl Miahipour, Mehdi Yousefi

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies

    CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies حسب Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, Wanich Suksatan, Moaed E. Al‐Gazally, Walid Kamal Abdelbasset, Lakshmi Thangavelu, Alexei Valerievich Yumashev, Ali Hassanzadeh, Mahboubeh Yazdanifar, Roza Motavalli, Yashwant Pathak, Adel Naimi, Behzad Baradaran, Marzieh Nikoo, Farhad Motavalli Khiavi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: